Journey Medical Corp (DERM) Total liabilities 2020–2025
Journey Medical Corp (DERM) total liabilities at each fiscal year-end, per SEC filings.
$62.7MFY2025 · since FY2020: $41.6M → $62.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.7M | +4.3% |
| FY2024 | $60.2M | +6.5% |
| FY2023 | $56.5M | -35.9% |
| FY2022 | $88.2M | +59.6% |
| FY2021 | $55.2M | +32.7% |
| FY2020 | $41.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Shareholders’ equityDERM overview →